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Abstract
Traumatic brain injury (TBI) is a leading cause of injury-related death and disability worldwide. Effective treatment for TBI is
limited and many TBI patients suffer from neuropsychiatric sequelae. The molecular and cellular mechanisms underlying the
neuronal damage and impairment of mental abilities following TBI are largely unknown. Here we used the next generation
sequencing platform to delineate miRNA transcriptome changes in the hippocampus at 24 hours and 7 days following TBI in
the rat controlled cortical impact injury (CCI) model, and developed a bioinformatic analysis to identify cellular activities that
areregulatedbymiRNAsdifferentiallyexpressed inthe CCI brains. The results of ourstudy indicate thatdistinct sets of miRNAs
are regulated at different post-traumatic times, and suggest that multiple miRNA species cooperatively regulate cellular
pathwaysforthepathologicalchangesandmanagementofbraininjury.ThedistinctivemiRNAsexpressionprofilesatdifferent
post-CCI times may be used as molecular signatures to assess TBI progression. In addition to known pathophysiological
changes, our study identifies many other cellular pathways that are subjected to modification by differentially expressed
miRNAs in TBI brains. These pathways can potentially be targeted for development of novel TBI treatment.
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Introduction
Traumatic brain injury (TBI) is an insult to the brain from the
application of external physical force that leads to temporary or
permanent structural and functional impairment of the brain. TBI
is a leading cause of injury-related death and disability [1]. Around
1.7 million people sustain a TBI in the U.S. annually and 53,000
of them die from TBI-related injuries [2,3]. In TBI survivors,
neuropsychiatric abnormalities, such as cognitive deficits, emo-
tional and behavioral problems are common and contribute
substantially to post-TBI disabilities [4]. The hippocampus is an
essential brain region for cognition and emotion [5], and is
vulnerable to TBI. TBI-related hippocampal damages, such as cell
loss, disturbed neural circuits and impaired synaptic transmission
and synaptic plasticity, are major pathophysiological changes in
TBI [6,7,8], and are expected to lead to neuropsychiatric
symptoms. However, the molecular and cellular mechanisms
responsible for hippocampal damage and recovery following TBI
are poorly understood. The structural and functional modification
of the brain entails gene expression changes. In fact, studies in
both humans and animal models of TBI show that gene expression
is altered by TBI in multiple brain regions [9,10,11,12], but the
molecular mechanisms underlying TBI-induced gene expression
changes are unclear.
MicroRNAs (miRNAs) are a class of small non-coding RNAs
which repress gene expression at the post-transcriptional level by
translational inhibition and/or promoting mRNA degradation
throughbindingofthemiRNAseed regions(usuallynucleotides2–8
at the 59 end) to their binding sites in the 39 untranslated region (39
UTR) of the target mRNAs [13]. Each miRNA can potentially
target up to hundreds of protein-coding transcripts due to imperfect
base pairing between miRNAs and their targets. Hence, miRNAs
exert pleiotropic effects on gene expression and regulate diverse
biological processes, such as cell proliferation and differentiation
and apoptosis [14]. Over 1000 miRNAs have been identified in
mammals and hundreds of them are expressed in the brain [15,16].
miRNAs are crucial for proper brain functions. Loss of miRNAs in
mice due to deficient expression of Dicer and DGCR8, which are
two miRNA processing molecules, causes changes in synaptic
protein expression, synaptic transmission, dendritic spine morphol-
ogy, learning and memory [17,18]. It has been reported that TBI
alters miRNA expression in the hippocampus [19]. Because
changed miRNA expression is predicted to influence their target
mRNA expression, it is possible that miRNAs play a role in
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39357regulatinggene expressioninTBI.Hence, a comprehensive analysis
of miRNA expression profiles and identification of miRNAs
modulated in TBI are essential to construct the signaling network
responsible for TBI-induced gene expression changes.
Animal models are important tools for studying TBI. The lateral
fluid percussion injury (FPI) model and the controlled cortical
impact injury (CCI) model are two widely used animal models of
focal TBI. FPI is delivered through a pressurized pulse of saline
solution created by a piston [20]. CCI is produced by a rigid
impactor which delivers a mechanical energy to the intact dura.
The parameters of CCI, such as impact velocity and depth, can be
fine-tuned by adjusting the settings of the impactor, allowing
injury severity to be precisely controlled [21].
Here, by employing the next generation sequencing platform,
we analyze the miRNA transcriptomes in the rat hippocampus at
24 hours and 7 days after TBI in the CCI model. Deep sequencing
provides superb sensitivity, quantifiability and throughput over
microarray and quantitative RT-PCR assays for miRNAs. We
show that distinct miRNAs are up- or down-regulated at the two
post-CCI time points. To decipher the biological implication of
altered miRNA expression, we design a miRNA-gene-GO
enrichment analysis to identify biological functions that are
regulated by the target genes of changed miRNAs. We find that
different gene ontology (GO) terms are targeted by the miRNAs
altered in expression at the early and late phase of TBI.
Intriguingly, the biological processes associated with these GO
terms are consistent with the characteristic post-CCI pathological,
physiological and structural changes. These findings indicate that
miRNA expression profile changes are a distinctive molecular
signature of post-TBI brains, and regulation of gene expression by
miRNAs might be an important component of the cellular
programs used by the injured brain to modulate gene expression
for management and repair of injury-related cell damages.
Results
miRNA Transcriptome Changes in the Hippocampus
Following CCI Injury
To interrogate the effect of TBI on miRNA expression, we used
Illumina sequencing to analyze CCI-induced miRNA transcrip-
tome changes. Male rats aged 60 days were sham operated or
subjected to CCI (3–4 rats for each condition), and euthanized for
collection of brain tissues at 24 hours and 7 days after CCI. RNA
was extracted from the dorsal hippocampus, which corresponds to
the human posterior hippocampus and is involved in learning and
memory [5], and assessed for RNA quality by measuring the RNA
integrity number (RIN) (Table S1). Sequencing libraries were
prepared from miRNAs extracted from the dorsal hippocampus
on the injured side of the brain (Figure S1A) and sequenced using
an Illumina GAII analyzer. 0.64–1.0 million quality-filtered reads
(see deep-sequencing data analysis in Materials and Methods) were
obtained from each sample, 89–93% of them were mapped to
mature rat miRNAs, and 328 mature rat miRNAs were identified
from the total of 12,520,384 mapped reads from 15 rats (Table
S1). The number of miRNAs detected by our assay is in line with a
recent report that 294 miRNAs are detected in the mouse brain
[15].
The normalized tag counts of individual miRNAs in each
library were used to assess their relative abundance. The fold
change and p-values of miRNA expression changes detected by
deep sequencing were illustrated in Figure 1, 2. In the MA plots of
Figure 1A, C, the fold changes were randomly distributed around
zero, but independent on the relative expression levels of
individual miRNAs. This observation indicates that our deep
sequencing was unbiased on miRNA abundance. The p-values of
both the 24-hour and 7-day datasets were uniformly distributed
between 0 and 1 (Figure S1B, C), thus the null hypothesis was true
and the assumption of t-test was satisfied. It is worth noting that all
miRNAs with p-values less than 0.05 had absolute fold changes
greater than 1 (Figure 1B, D). The correlation between p-value
and fold change indicates that the statistical significance and the
biological significance of the sequencing result are consistent.
To validate the results of deep sequencing with an independent
assay, we used quantitative reverse transcription polymerase chain
reaction (qRT-PCR) to measure the expression change of miR-
124, miR-135, miR-153 and miR-222. As shown in Figure 1E, F,
miR-153 expression was elevated and miR-222 expression was
decreased at 24 hours post-CCI; expression of both miR-135a and
miR-135b was reduced at 7 days post-CCI; miR-124 expression
was comparable in control and CCI samples at both the 24-hour
and 7-day time points. These qRT-PCR results were consistent
with the findings from deep sequencing (Figure 1A–D).
By using deep-sequencing, we found that 13 miRNAs were
down-regulated and 8 miRNAs were up-regulated at 24 hours
after CCI (p,0.05, Figure 1A, B). Among the 21 miRNAs altered
at 24 hours, 5 (miR-144, miR-136, miR-148b-5p, miR-342-5p,
miR-23a*) showed persistent changes by 7 days after CCI
(Figure 1C, D). The number of changed miRNAs was reduced
to 10 (7 down-regulated and 3 up-regulated) at 7 days post-CCI
(Figure 1C, D). These results show that up to 6% of miRNAs
expressed in the hippocampus are changed following CCI injury.
The finding that overlapping but distinct sets of miRNAs are
changed at 24 hours and 7 days post-CCI implicates that the
miRNA transcriptome change is a prominent molecular signature
of the injured brain for different post-injury times.
miRNA-gene-GO Enrichment Analysis of miRNAs Altered
by CCI Injury
The cellular and physiological effects of altered miRNA
expression are mainly mediated by their regulation of target
mRNAs. Many miRNAs are predicted to have hundreds of mRNA
targets, and each mRNA usually has binding sites for multiple
miRNA species. While the repressive effect of an individual miRNA
species on its target expression can be moderate, the combinatorial
control of a gene by multiple miRNA species that bind to the same
mRNA target, and the concurrent action of one miRNA species on
several target genes belonging to the same signaling pathway are
expected to regulate gene expression and biological functions in a
more robust and fine-tuned manner [22].
To test the possibility that multiple miRNA species function
cooperatively in TBI, we developed a miRNA-gene-GO enrich-
ment analysis to computationally examine the potential effects of
miRNA expression changes in CCI. The effect size of miRNA
expression change on its target gene expression and cellular
activities varies greatly among miRNAs, and is determined by the
fold change of the miRNAs. Because the absolute fold changes of
miRNAs positively correlate with their p-values (Figure 1B, D), to
select miRNAs likely to have decent effect sizes on cellular
functions and to retain a reasonable power of detection, we ranked
the miRNAs by their p-values and included those with p-values
less than 0.1 for the miRNA-gene-GO enrichment analysis. This
approach of using relaxed cutoff of p-values may give rise to more
false positives than more stringent methods, such as multiple
hypothesis testing, but the purpose of our bioinformatic analysis is
to predict potential cellular outcomes of miRNA expression
changes, hence some false positives are allowed. The TargetScan
and Gene Ontology database were used in this analysis for
miRNA target prediction and functional annotation of miRNA
miRNA Expression in Traumatic Brain Injury
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39357Figure 1. miRNA expression changes in the CCI brains. The hippocampus on the operated side of the brain was removed for miRNA
expression profiling by deep sequencing at 24 hours (A, B) and 7 days (C, D) after CCI. Each circle represents a miRNA species. (A, C) The fold change
(on log2 scale) of each miRNA species in CCI rats versus sham controls is plotted against its normalized read number (on log2 scale). (B, D) The p-value
(on log10 scale) of each miRNA species is plotted against its fold change (on log2 scale). Blue and green dots are miRNAs that have p-values less than
0.05. (E, F) The fold change (on log2 scale) of miRNAs analyzed by qRT-PCR. Data are presented as mean 6 s.e.m. Student’s t test was used for
statistical analysis. * p,0.05; ** p,0.01.
doi:10.1371/journal.pone.0039357.g001
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analysis, we relaxed the p-value cutoff to 0.1 to include more
miRNAs in the analysis. 29 (20 for 24 hours, 9 for 7 days) miRNAs
had higher expression levels in the CCI samples than in the sham
controls, and 39 (23 for 24 hours, 16 for 7 days) miRNAs showed
reduced expression in the CCI group compared to sham controls
(Table S2). We divided these miRNAs into 4 time- and change-
direction defined test groups: 24 hour positive change group, 24
hour negative change group, 7 day positive change group and 7
day negative change group (Table S2). Each test group was
analyzed independently.
The miRNA-gene-GO enrichment analysis was conducted in
three steps. Because the rat genome is annotated less well than the
mouse genome [23], to increase the coverage of genes, we used the
mouse genome in our analysis. First, we matched the rat miRNAs
identified by our deep sequencing to their mouse orthologs by
using the TargetScan database (http://www.targetscan.org/
mmu_50/mmu_50_data_download/Nonconserved_Family_Info.
txt.zip). Next, in the miRNA-gene step, we collected all
computationally predicted target genes of the mouse miRNA
orthologs from the TargetScan database, and estimated their
statistical significance of enrichment in each test group by using
hypergeometric test. The genes that have p-values less than 10
25 in
the enrichment test were considered over-represented. The number
of over-represented genes for each test group is shown in Table S2.
Lastly, in the gene-GO step, we obtained the GO terms that
annotated the over-represented genes from the Gene Ontology
database, and performed the enrichment analysis for each GO term
by using conditional hypergeometric test. GO terms with p-values
less than 0.05 were considered enriched. There were three sets of
GO terms: biological process (BP), molecular function (MF), and
cellular component (CC). The enriched GO terms of each category
are shown in Figures 3, 4, 5, and 6.
Some identified GO terms have common cellular functions. For
example, the GO-terms ‘‘mRNA export from nucleus’’, ‘‘nuclear
export’’ and ‘‘nucleus localization’’ are all related to nuclear
Figure 2. Heat map of miRNAs analyzed in the CCI brain. Heat map of mean signal intensities following normalization for all miRNAs detected
in the CCI and sham control hippocampi by deep sequencing.
doi:10.1371/journal.pone.0039357.g002
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common functions together to obtain a generalized picture of the
biological functions regulated by differentially expressed miRNAs.
At 24 hours post-CCI, up-regulated miRNAs were enriched in cell
proliferation and differentiation, chromatin remodeling, nuclear
transport, protein synthesis and processing, synaptic transmission
and white blood cell apoptosis (Table S3). miRNAs down-
regulated at 24 hours post-CCI targeted to aerobic respiration,
alternative splicing, protein maturation, protein catabolism,
ribonucleoside metabolism, androgen signaling and intracellular
Figure 3. Genes and GO terms in the biological process ontology that are over-represented by differentially expressed miRNAs at
24 hours post-CCI. (A) Genes and GO terms enriched by down-regulated miRNAs. (B) Genes and GO terms enriched by up-regulated miRNAs.
doi:10.1371/journal.pone.0039357.g003
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39357Figure 4. Genes and GO terms in the cellular component and the molecular function ontology that are over-represented by
differentially expressed miRNAs at 24 hours post-CCI. (A) Genes and GO terms in the cellular component ontology enriched by down-
regulated miRNAs. (B) Genes and GO terms in the cellular component ontology enriched by up-regulated miRNAs. (C) Genes and GO terms in the
molecular function ontology enriched by down-regulated miRNAs. (D) Genes and GO terms in the molecular function ontology enriched by up-
regulated miRNAs.
doi:10.1371/journal.pone.0039357.g004
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different miRNA expression patterns revealed by miRNA
profiling, only intracellular signaling, protein maturation and
alternative splicing were also targeted by miRNAs altered at 7 days
post-CCI (Table S3). In addition to these functions conserved at
both time points, at 7 days post-CCI, actin polymerization, cell-
matrix adhesion, cellular response to ROS, intracellular traffick-
ing, lipid metabolism and gene expression were targeted by up-
Figure 5. Genes and GO terms in the biological process ontology that are over-represented by differentially expressed miRNAs at 7
days post-CCI. (A) Genes and GO terms enriched by down-regulated miRNAs. (B) Genes and GO terms enriched by up-regulated miRNAs.
doi:10.1371/journal.pone.0039357.g005
miRNA Expression in Traumatic Brain Injury
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39357regulated miRNAs, and down-regulated miRNAs were selective to
actin depolymerization, alternative splicing, protein maturation,
RNA degradation, nutrient metabolism, DNA repair and synap-
togenesis (Table S3).
The GO enrichment and clustering analysis reveals that: 1. at
the early times after brain injury, miRNAs might be involved in
the inhibition of white blood cell apoptosis to augment the
inflammatory response, the dampening of transcription and
facilitation of protein folding and catabolism to reduce stress-
induced denaturation and aggregation of intracellular proteins,
and the promotion of aerobic respiration to exert protective
actions; 2. At the later post-CCI times, miRNAs preferentially
regulate gene expression, intracellular trafficking and metabolism,
cytoskeleton and cell adhesion to allow cell structure remodeling
and synaptogenesis for repair of neuronal circuitry. These findings
suggest that miRNAs are involved in both the early post-CCI
Figure 6. Genes and GO terms in the cellular component and the molecular function ontology that are over-represented by
differentially expressed miRNAs at 7 days post-CCI. (A) Genes and GO terms in the cellular component ontology enriched by down-regulated
miRNAs. (B) Genes and GO terms in the cellular component ontology enriched by up-regulated miRNAs. (C) Genes and GO terms in the molecular
function ontology enriched by down-regulated miRNAs. (D) Genes and GO terms in the molecular function ontology enriched by up-regulated
miRNAs.
doi:10.1371/journal.pone.0039357.g006
miRNA Expression in Traumatic Brain Injury
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e39357pathological changes and stress management, and the later brain
repair mechanisms.
Discussion
In this study, we examine the effect of CCI injury on the
miRNA transcriptome in the hippocampus, and identify cellular
functions and biological processes that are potentially regulated by
miRNAs in the injured hippocampus. Our findings reveal that
distinct sets of miRNAs are regulated at different post-CCI time
points. To enquire the biological pathways targeted by the
differentially-expressed miRNAs in a high-throughput manner
and obtain a comprehensive view on the functional significance of
miRNAs in TBI, we developed the miRNA-gene-GO enrichment
analysis to functionally annotate miRNA expression changes. Our
bioinformatic analysis shows that miRNAs target to multiple GO
terms in a post-CCI-time-specific way. These findings indicate that
miRNAs act in concert to regulate a broad range of cellular
functions in the brain at different stages of TBI.
The fact that both up- and down-regulation of miRNAs are
detected in the injured hippocampus indicates that the miRNA
expression change is not caused by global changes of miRNA
biogenesis or turnover. The observations that more miRNAs are
altered at 24 hours than at 7 days post-CCI and that ,75% of
miRNAs changed at 24 hours restore their expression levels at 7
days suggest that the mechanisms to alter miRNA expression at
various post-CCI times are different. In addition to the number, the
identities of miRNAs altered at the two post-CCI time points that
we examined are also different, thus each post-CCI stage has a
unique miRNA expression profile, which can be potentially used as
molecular markers for TBI progress. Redell and colleagues have
used the microarray assay to examine miRNA expression changes
at 3 hour and 24 hour after CCI [19]. The pool of differentially
expressed miRNAs identified by their study does not overlap with
our results. The discrepancy may be related to the difference in
miRNA detection method (deep sequencing vs. microarray), and
higher impact strength and older rats used in the Redell et al. study.
miRNA expression changes may be the outcome of injury-related
pathological changes in the brain, such as cell death and
neuroinflammation. If this is the case, we predict a uniform change
direction for all or the majority of miRNA species, but only 6% of
miRNAs detected in the hippocampus show altered expression, and
both increases and decreases are observed, suggesting that miRNAs
do not passively respond to injury. It is likelythat modulating miRNA
expression is an active approach taken by cells to cope with injury.
What is the consequence of miRNA expression changes? A
miRNA usually has numerous mRNA targets and the effect of
altering a single miRNA species on its targets may be moderate.
The robustness of miRNA mediated gene expression regulation
can be enhanced through cooperative action of several types of
miRNAs that bind to the same target gene or to several genes
serving for the same cellular process. We designed a miRNA-gene-
GO enrichment analysis to test if distinct miRNAs changed in the
same direction would also coordinately regulate cellular functions.
miRNAs changed in the same direction have similar effects on
their target expression, hence are put in the same group for the
test. The results of our analysis show that many differentially
expressed miRNAs are related to common GO terms. Both 24
hours and 7 days post-CCI correspond to the secondary damage
stage of TBI, which occurs at minutes to days and even months
after the initial trauma as the results of delayed histological,
biochemical, metabolic and cellular changes [24,25]. Studies using
TBI animal models show that the increase of intracellular calcium
resulting from altered balance of excitatory and inhibitory synaptic
transmission triggers a cascade of events in the cell, such as
reactive oxygen species production, calpain activation and
mitochondrial damage [26,27,28]. These cellular responses are
essential to the initiation of secondary damage [24], and are
predicted to play important roles in TBI-related structural and
functional impairment of neurons. The findings of our miRNA-
gene-GO enrichment analysis are consistent with the known post-
trauma-pathophysiological changes. For example, GO related to
synaptic transmission, cellular response to ROS and aerobic
respiration are targeted by miRNAs changed in CCI brains. In
addition to the known cellular changes, our results show that many
other cellular pathways, which are not recognized in previous TBI
studies, are targeted by miRNAs in TBI brains.
The fact that distinct GO terms are identified for the two post-
CCI time points is intriguing. At 24 hours post-CCI, miRNAs are
modulated to inhibit leukocyte cell death for the inflammatory
response, prevent stress-induced protein denaturation and aggre-
gation, and protect cells from energy exhaustion. At the later
recovery-oriented time, cells switch to miRNAs that bolster a
permissive cellular environment for cell repair and structural
remodeling. Hence, miRNA mediated gene expression regulation
is an integral component of the cellular strategies to adapt to,
compensate for and repair brain damages from traumatic brain
injury. Future studies to understand the specific functions of each
differentially expressed miRNA and the significance of the targeted
cellular pathways for TBI may contribute to the amelioration of
long-term cognitive dysfunction as a consequence of brain injury.
Materials and Methods
Controlled Cortical Impact (CCI) Injury
CCI injury was performed in male rats (Sprague Dawley, 200 g)
as previously described [29,30]. Briefly, rats were anesthetized
with isoflurane and placed on a stereotaxic device. A 4.0 mm hole
was made in the skull over the left tempoparietal cortex to expose
the dura. Each animal received a single contusion (deformation
depth: 2 mm; velocity: 3.5 m/sec; dwell time: 200 ms) applied
through an impact tip (3 mm in diameter). Following CCI, the
burr hole was covered with the skull cap, sealed with bone wax,
and scalp sutured. Sham-operated control rats were operated
similarly, but received no cortical impact.
miRNA Sequencing Library Construction and Deep
Sequencing
Dorsal hippocampi of rats were removed and homogenized with
a Polytron homogenizer (Kinematica) in the lysis buffer provided
by the mirVana miRNA Isolation Kit (Ambion). The lysate was
then extracted with acid-phenol:chloroform, added ethanol to
bring up the sample to 25% ethanol and fractionated to isolate the
large and small RNAs by using the glass-fiber filter of mirVana
miRNA Isolation Kit. miRNAs were purified from the small RNA
fraction by using denaturing polyacrylamide gel electrophoresis
(15%) followed by recovering the 17,27-nt-long RNA fragments
which were enriched for miRNAs. RNA integrity number (RIN) of
the extracted RNA samples was measured to assess RNA quality
by using the Agilent 2100 Bioanalyzer. Deep-sequencing libraries
were constructed by using the Small RNA Sample Prep kit
(Illumina). Briefly, 39 adaptors and 59 adaptors were ligated to
purified miRNAs sequentially. The adaptor tagged miRNAs were
reverse-transcribed and PCR amplified. The PCR products were
purified by polyacrylamide gel electrophoresis (8%) and sequenced
by using an Illumina Genome Analyzer II.
miRNA Expression in Traumatic Brain Injury
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Sequence data analysis was performed as described previ-
ously [31]. Briefly, raw sequence reads were first consolidated
by clustering identical sequence reads and only those contain-
ing complete 39 and 59 adaptor sequences were subjected to
downstream analysis. After trimming of 39 and 59 adaptor
sequences, the remaining sequences were aligned to the
miRNA hairpin sequences downloaded from miRBase database
release (http://www.mirbase.org/) by using Bowtie v0.2.13
[32]. The mappable reads were further filtered to remove those
which did not map to mature miRNAs. The expression count of
each type of miRNA was normalized to the total number of
mapped reads of the corresponding sample [33]. Linear
models, empirical Bayes methods [34] and Student’s t test
were used for statistics.
miRNA-gene-GO Enrichment Analysis
The following equation was used for the hypergeometric
statistical test in the gene enrichment analysis for each test group
(e.g. 24 h positive).
n11= the number of miRNAs in the test group that target to the
gene being tested; n12= the number of other detected miRNAs
that had the same change direction as those in the test group, and
target to the gene being tested, but were not included in the test
group because their p-values were greater than 0.1; n21= the
number of miRNAs in the group that do NOT target to the gene
being tested; n22= the number of other miRNAs that had the
same change direction as those in the test group, but do NOT
target to the gene being tested, and were not included in the test
group because their p-values were greater than 0.1.
The enriched GO terms that annotate the over-represented
genes were identified by using the conditional hypergeometric
statistical test [R package GOStats, [35]]. The GO terms whose
statistical significance was contributed by their significant children
terms were removed in the conditional hypergeometric test. GO
terms that had p-values less than 0.05 and were annotations for
$2 over-represented genes that were targeted by $2 miRNAs in
the test group were considered statistically enriched. The following
equation was used for the test.
m11= the number of over-represented genes in the test group that
were mapped to the GO term being tested; m12= the number of
other genes in the GO database that were mapped to the GO term
being tested; m21= the number of over-represented genes in the
test group were NOT mapped to the GO term being tested; m22=
the number of other genes in the GO database that were NOT
mapped to the GO term being tested.
qRT-PCR
miRNAs were extracted by using the mirVana miRNA
Isolation Kit (Ambion). The TaqMan miRNA assay kit (Applied
Biosystems) was used for qRT-PCR of miRNAs. Briefly, miRNAs
were transcribed into cDNAs and amplified by PCR with the
Taqman primers specific for miRNAs of interest by using the
Applied Biosystems 7900 Fast Real-Time PCR System according
to the manufacture’s manual. U6 was used as the endogenous
control gene to normalize input amounts.
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Figure S1 P-value distribution for miRNAs detected in the
rat hippocampus by deep-sequencing. (A) Representative gel
image of miRNA deep-sequencing libraries. (B) Frequency histogram
of p-valuesfor miRNAs analyzed at 24 hourspost-CCI. (C) Frequency
histogram of p-values for miRNAs analyzed at 7 days post-CCI.
(TIF)
Table S1 RIN and summary of deep-sequencing reads.
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